PubRank

Peter Richmond

Author PubWeight™ 59.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2009 3.32
2 Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population. J Infect Dis 2013 1.64
3 Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 2006 1.57
4 Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect Immun 2002 1.46
5 The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Clin Infect Dis 2010 1.30
6 Infection is the major component of the disease burden in aboriginal and non-aboriginal Australian children: a population-based study. Pediatr Infect Dis J 2007 1.26
7 Innate immunity in human newborn infants: prematurity means more than immaturity. J Matern Fetal Neonatal Med 2010 1.25
8 Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule. Vaccine 2011 1.24
9 A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Vaccine 2007 1.17
10 Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff. Osteoporos Int 2003 1.15
11 Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants. Pediatrics 2011 1.11
12 Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children. Infect Immun 2005 1.09
13 Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism. Lancet 2002 1.08
14 The role of chronic infection in children with otitis media with effusion: evidence for intracellular persistence of bacteria. Otolaryngol Head Neck Surg 2008 1.06
15 Diverging trends for lower respiratory infections in non-Aboriginal and Aboriginal children. J Paediatr Child Health 2007 1.04
16 TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. PLoS One 2010 1.04
17 A retrospective population-based cohort study identifying target areas for prevention of acute lower respiratory infections in children. BMC Public Health 2010 1.02
18 Use of data linkage to investigate the aetiology of acute lower respiratory infection hospitalisations in children. J Paediatr Child Health 2011 0.99
19 Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 2011 0.98
20 Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatr Infect Dis J 2013 0.97
21 Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol 2006 0.95
22 The burden of rotavirus-related illness among young children on the Australian health care system. Aust N Z J Public Health 2006 0.95
23 Responsiveness of human monocytes to the commensal bacterium Staphylococcus epidermidis develops late in gestation. Pediatr Res 2012 0.95
24 Neonatal immune responses to coagulase-negative staphylococci. Curr Opin Infect Dis 2007 0.92
25 Theoretical analysis and simulations of the generalized Lotka-Volterra model. Phys Rev E Stat Nonlin Soft Matter Phys 2002 0.92
26 Method of bacterial killing differentially affects the human innate immune response to Staphylococcus epidermidis. Innate Immun 2010 0.91
27 Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. Vaccine 2012 0.91
28 Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus. Infect Immun 2011 0.90
29 Predictors of disease severity in children hospitalized for pertussis during an epidemic. Pediatr Infect Dis J 2015 0.88
30 Development of improved vaccines against whooping cough: current status. Hum Vaccin 2010 0.88
31 Can linked emergency department data help assess the out-of-hospital burden of acute lower respiratory infections? A population-based cohort study. BMC Public Health 2012 0.87
32 Seasonality of respiratory viral identification varies with age and Aboriginality in metropolitan Western Australia. Pediatr Infect Dis J 2009 0.87
33 Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine 2010 0.86
34 Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness. Expert Rev Vaccines 2015 0.86
35 Effect of early carriage of Streptococcus pneumoniae on the development of pneumococcal protein-specific cellular immune responses in infancy. Pediatr Infect Dis J 2012 0.85
36 The burden of pneumonia in children: an Australian perspective. Paediatr Respir Rev 2005 0.85
37 Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials 2013 0.84
38 Phagocytosis of neonatal pathogens by peripheral blood neutrophils and monocytes from newborn preterm and term infants. Pediatr Res 2013 0.84
39 Skin prick testing predicts peanut challenge outcome in previously allergic or sensitized children with low serum peanut-specific IgE antibody concentration. Pediatr Allergy Immunol 2007 0.84
40 CD46 measles virus receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive Australian children. Clin Vaccine Immunol 2012 0.83
41 Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics 2008 0.83
42 Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique. Vaccine 2012 0.83
43 The effects of maternal smoking on early mucosal immunity and sensitization at 12 months of age. Pediatr Allergy Immunol 2007 0.82
44 SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine. Vaccine 2011 0.82
45 Detection of biofilm in bronchoalveolar lavage from children with non-cystic fibrosis bronchiectasis. Pediatr Pulmonol 2014 0.82
46 Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine. Immunogenetics 2011 0.81
47 TLR3 and RIG-I gene variants: associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants. Hum Immunol 2012 0.81
48 A national prospective surveillance study of acute rheumatic fever in Australian children. Pediatr Infect Dis J 2013 0.80
49 A genomics-based approach to assessment of vaccine safety and immunogenicity in children. Vaccine 2012 0.80
50 NOD1 and NOD2 expression and function in very preterm infant mononuclear cells. Acta Paediatr 2014 0.79
51 Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine 2011 0.79
52 New horizons: otitis media research in Australia. Med J Aust 2009 0.79
53 Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers. Pediatr Infect Dis J 2013 0.79
54 Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age. Pediatr Infect Dis J 2011 0.78
55 A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers. Pediatr Infect Dis J 2012 0.78
56 Group A Streptococcal Carriage and Seroepidemiology in Children up to 10 Years of Age in Australia. Pediatr Infect Dis J 2015 0.77
57 Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants. Vaccine 2006 0.77
58 Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers. Pediatr Infect Dis J 2015 0.77
59 Meningitis in children in Fiji: etiology, epidemiology, and neurological sequelae. Int J Infect Dis 2012 0.77
60 Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials. Hum Vaccin Immunother 2012 0.77
61 DTPa-HBV-IPV vaccine for primary vaccination of infants. J Paediatr Child Health 2007 0.76
62 Finding pneumo: purulent pericarditis presenting with pulsus paradoxus. Crit Care Resusc 2007 0.75